The novel potent Pan-TEAD inhibitor, SB6863, inhibits oncogenic YAP1/TAZ-TEAD signaling and exhibits robust tumor regression in preclinical mesothelioma models

被引：0
|
作者：
Lee, O. Y. [1 ]
Jeong, Y. [1 ]
Park, Y. [1 ]
Kim, J. G. [1 ]
Choi, S. [1 ]
Jung, H. S. [1 ]
Kong, Y. [1 ]
Baek, G. R. [1 ]
Kim, J. H. [1 ]
Kim, H. E. [1 ]
Yoo, J. W. [1 ]
Park, J. H. [1 ]
Jeong, H. U. [1 ]
Park, H. [1 ]
Kim, M. K. [1 ]
机构：
[1] Dong A ST Co Ltd, Res Headquarter, Yongin, Gyeonggi Do, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114648
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB113
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 4 条
  • [1] The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma
    Kaneda, Ayumi
    Seike, Toshihiro
    Danjo, Tomohiro
    Nakajima, Takahiro
    Otsubo, Nobumasa
    Yamaguchi, Daisuke
    Tsuji, Yoshiro
    Hamaguchi, Kaori
    Yasunaga, Mai
    Nishiya, Yoichi
    Suzuki, Michihiko
    Saito, Jun-ichi
    Yatsunami, Rie
    Nakamura, Satoshi
    Sekido, Yoshitaka
    Mori, Kiyotoshi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (12): : 4399 - 4415
  • [2] OPN-9840, a non-covalent potent pan-TEAD inhibitor, exhibits single agent efficacy in preclinical malignant mesothelioma models
    Chen, Pan-Yu
    Matusow, Bernice
    Tsai, James
    Li, Peipei
    Hoa Nguyen
    Habets, Gaston
    Bollag, Gideon
    Chowdhury, Somenath
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Discovery of a first-in-class TEAD inhibitor which directly inhibits YAP/TAZ-TEAD protein-protein interaction and shows a potent anti-tumor effect in malignant pleural mesothelioma
    Kaneda, Ayumi
    Seike, Toshihiro
    Uemori, Takeshi
    Myojo, Kensuke
    Aida, Kensuke
    Danjo, Tomohiro
    Nakajima, Takahiro
    Yamaguchi, Daisuke
    Hamada, Tomoko
    Tsuji, Yoshiro
    Hamaguchi, Kaori
    Yasunaga, Mai
    Otsubo, Nobumasa
    Onodera, Hideyuki
    Nishiya, Yoichi
    Suzuki, Michihiko
    Saito, Junichi
    Ishii, Toshihiko
    Nakai, Ryuichiro
    CANCER RESEARCH, 2019, 79 (13)
  • [4] ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong antitumor activity in preclinical models of Hippo pathway-dysregulated cancers
    Li, Qi
    Wan, Jainfei
    Liu, Jinxin
    Shang, Jing
    Yu, Jiaojiao
    Zhu, Wei
    Chen, Celia X. -J.
    Qiao, Junwen
    Wang, Ling
    Zhang, Man
    Ding, Xiao
    Bavadekar, Supriya
    Rao, Sujata
    Ren, Feng
    Zhavoronkov, Alex
    CANCER RESEARCH, 2024, 84 (06)
1